PharmaCyte Biotech annual operating margin
2012
2013
PharmaCyte Biotech Operating Margin Growth & History (PMCB)
PharmaCyte Biotech's operating margin was −13,851.65% for fiscal 2013.
View full PharmaCyte Biotech company overviewPharmaCyte Biotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2013 | 2013-04-30 | −13,851.65% | −10923.11 pp |
| 2012 | 2012-04-30 | −2,928.55% | — |
PharmaCyte Biotech quarterly operating margin
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2013 | 2012-10-31 | −5,547.89% | −3513.37 pp |
| Q1 2013 | 2012-07-31 | −8,131.39% | −4829.09 pp |
| Q4 2012 | 2012-04-30 | −7,227.48% | — |
| Q3 2012 | 2012-01-31 | −2,022.51% | — |
| Q2 2012 | 2011-10-31 | −2,034.52% | — |
| Q1 2012 | 2011-07-31 | −3,302.30% | — |
PharmaCyte Biotech operating margin trends
Across the available reported history, PharmaCyte Biotech's operating margin decreased from −2,928.55% to −13,851.65%, a change of −10923.11 percentage points. The latest reported quarter, Q2 2013, shows −5,547.89%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PharmaCyte Biotech filings at SEC.gov ↗